| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 313.87B | 301.10B | 287.88B | 272.58B | 255.05B | 231.25B |
| Gross Profit | 86.62B | 81.59B | 68.99B | 62.98B | 61.12B | 57.90B |
| EBITDA | 41.35B | 35.98B | 27.67B | 22.38B | 23.08B | 22.23B |
| Net Income | 22.19B | 18.49B | 11.21B | 7.13B | 6.73B | 7.30B |
Balance Sheet | ||||||
| Total Assets | 356.72B | 341.35B | 334.79B | 307.39B | 290.90B | 279.06B |
| Cash, Cash Equivalents and Short-Term Investments | 31.22B | 30.68B | 18.98B | 14.92B | 14.07B | 14.31B |
| Total Debt | 49.77B | 46.31B | 56.50B | 51.94B | 49.70B | 48.87B |
| Total Liabilities | 200.01B | 199.13B | 205.30B | 196.51B | 185.47B | 179.32B |
| Stockholders Equity | 153.25B | 138.78B | 126.41B | 107.90B | 101.97B | 96.53B |
Cash Flow | ||||||
| Free Cash Flow | 7.24B | 24.91B | -375.00M | 1.35B | 2.48B | -1.01B |
| Operating Cash Flow | 22.28B | 35.45B | 8.97B | 13.74B | 11.39B | 14.60B |
| Investing Cash Flow | -12.60B | -9.06B | -7.55B | -10.51B | -7.50B | -13.12B |
| Financing Cash Flow | -11.85B | -14.54B | 749.00M | -2.69B | -4.27B | -1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥301.90B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥279.73B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥378.83B | 8.30 | 14.28% | 2.40% | 8.03% | 23.50% | |
71 Outperform | ¥502.99B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥390.35B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥536.81B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |